Similarly, Bartstra et al. (18) found that six months of vitamin K2 supplementation (360 μg/day) did not halt the progression of arterial calcification or decline in BMD in patients with type 2 diabetes mellitus (T2DM) and a history of cardiovascular disease (CVD) although it reduced inactive MGP. This evidence concerns the gene MGP and type 2 diabetes mellitus.